Back to search
Inclusion Body Myositis, Sporadic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inclusion Body Myositis, Sporadic trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Inclusion Body Myositis, Sporadic trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Refer to the "Detailed Description" section.
To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in patients with sIBM
This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits t…
This is a pilot study (phase 1 clinical trial) to evaluate the safety and tolerability of phenylbutyrate in IBM. In this open label study, 10 patients with spor…